Asia Pacific Custom Antibody Market Size & Outlook
Related Markets
Asia Pacific custom antibody market highlights
- The Asia Pacific custom antibody market generated a revenue of USD 27.7 million in 2023.
- The market is expected to grow at a CAGR of 11.7% from 2024 to 2030.
- In terms of segment, monoclonal antibodies was the largest revenue generating type in 2023.
- Recombinant antibodies is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 27.7 million |
| Market revenue in 2030 | USD 59.9 million |
| Growth rate | 11.7% (CAGR from 2023 to 2030) |
| Largest segment | Monoclonal antibodies |
| Fastest growing segment | Recombinant antibodies |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Monoclonal antibodies, Polyclonal antibodies, Recombinant antibodies, Other Type |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 17.5% of the global custom antibody market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 59.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Custom Antibody Market Scope
Custom Antibody Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Creative Diagnostics | View profile | 51-100 | New York, New York, United States, North America | http://www.creative-diagnostics.com |
| Kaneka Corp | View profile | 13284 | 3-2-4, Nakanoshima, Kita-ku, Osaka, Japan, 530-8288 | http://www.kaneka.co.jp |
| Labcorp Drug Development | View profile | 10001+ | Princeton, New Jersey, United States, North America | https://drugdevelopment.labcorp.com |
| Genscript Biotech Corp Class H | View profile | 6937 | No. 28, Yongxi Road, Jiangning Science Park, Jiangsu Province, Nanjing, China, People's Republic of, 211100 | https://www.genscript.com |
| Abcam PLC | View profile | 1760 | Discovery Drive, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AX | https://www.abcam.com |
| Lifespan | View profile | 10001+ | Providence, Rhode Island, United States, North America | https://www.lifespan.org/ |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
Asia Pacific custom antibody market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to custom antibody market will help companies and investors design strategic landscapes.
Monoclonal antibodies was the largest segment with a revenue share of 50.54% in 2023. Horizon Databook has segmented the Asia Pacific custom antibody market based on monoclonal antibodies, polyclonal antibodies, recombinant antibodies, other type covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Asia Pacific custom antibody market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific custom antibody market databook
-
Our clientele includes a mix of custom antibody market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific custom antibody market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific custom antibody market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific custom antibody market size, by country, 2018-2030 (US$M)
Asia Pacific Custom Antibody Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
